Related Experiment Video
Updated: Nov 10, 2025

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method
Published on: October 7, 2025
A Systematic Review of MicroRNAs Involved in Cervical Cancer Progression
Rhafaela Lima Causin1, Ana Julia Aguiar de Freitas1, Cassio Murilo Trovo Hidalgo Filho2
1Molecular Oncology Research Center, Barretos Cancer Hospital, Teaching and Research Institute, Barretos-SP 14784-400, Brazil.
Abstract:
To obtain a better understanding on the role of microRNAs in the progression of cervical cancer, a systematic review was performed to analyze cervical cancer microRNA studies. We provide an overview of the studies investigating microRNA expression in relation to cervical cancer (CC) progression, highlighting their common outcomes and target gene interactions according to the regulatory pathways. To achieve this, we systematically searched through PubMed MEDLINE, EMBASE, and Google Scholar for all articles between April 2010 and April 2020, in accordance with the PICO acronym (participants, interventions, comparisons, outcomes). From 27 published reports, totaling 1721 cases and 1361 noncancerous control tissue samples, 26 differentially expressed microRNAs (DEmiRNAs) were identified in different International Federation of Gynecology and Obstetrics (FIGO) stages of cervical cancer development. It was identified that some of the dysregulated microRNAs were associated with specific stages of cervical cancer development. The results indicated that DEmiRNAs in different stages of cervical cancer were functionally involved in several key hallmarks of cancer, such as evading growth suppressors, enabling replicative immortality, activation of invasion and metastasis, resisting cell death, and sustained proliferative signaling. These dysregulated microRNAs could play an important role in cervical cancer's development. Some of the stage-specific microRNAs can also be used as biomarkers for cancer classification and monitoring the progression of cervical cancer.
Insights
This systematic review identifies 26 differentially expressed microRNAs (DEmiRNAs) crucial for cervical cancer (CC) progression. These microRNAs are linked to key cancer hallmarks and may serve as biomarkers for CC classification and monitoring.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression.
- Dysregulation of miRNA expression is implicated in various cancers, including cervical cancer (CC).
- Understanding miRNA roles in CC progression is vital for developing diagnostic and therapeutic strategies.
Purpose of the Study:
- To systematically review and analyze studies on miRNA expression in cervical cancer progression.
- To identify common outcomes and target gene interactions of miRNAs in CC.
- To explore the potential of miRNAs as biomarkers for CC classification and monitoring.
Main Methods:
- Systematic literature search of PubMed MEDLINE, EMBASE, and Google Scholar (April 2010-April 2020).
- Inclusion of 27 published reports involving 1721 CC cases and 1361 noncancerous controls.
- Analysis based on PICO (participants, interventions, comparisons, outcomes) criteria.
Main Results:
- Identified 26 differentially expressed microRNAs (DEmiRNAs) across different International Federation of Gynecology and Obstetrics (FIGO) stages of CC.
- Found associations between specific dysregulated miRNAs and distinct stages of CC development.
- DEmiRNAs were functionally involved in core cancer hallmarks: evading growth suppressors, replicative immortality, invasion/metastasis, resisting cell death, and sustained proliferation.
Conclusions:
- Dysregulated miRNAs play a significant role in the development and progression of cervical cancer.
- Stage-specific miRNAs show potential as biomarkers for CC classification and monitoring.
- Further research into miRNA regulatory pathways could lead to novel therapeutic targets for CC.
Related Concept Videos
MicroRNAs
MicroRNAs

